As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview

Feb.10.2025
As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview
India supplies 85% of global nicotine, making it key to the NGP industry’s raw material chain. As regulations and consumer trends evolve, leading manufacturer Nico Orgo advocates natural nicotine over synthetic, emphasizing purity, innovation, and supply stability. Kartik Laijawala, Director at Nico Orgo, shares how the company navigates tightening regulations on synthetic nicotine and disposable vapes, leveraging its expertise to shape the industry's future.

Interview Highlights

 

• The Rise of Vapor-Free Nicotine Products: With increasing regulatory scrutiny on disposable vapes, the industry is shifting toward odorless, vapor-free nicotine delivery systems. Laijawala sees this as a defining trend and highlights Nico Orgo’s investment in next-generation nicotine formulations.

 

• Regulatory Crackdowns on Disposable Vapes: As global governments impose stricter controls, Laijawala believes this could drive demand for liquid nicotine products and alternative delivery formats.

 

• Natural vs. Synthetic Nicotine: Nico Orgo favors natural nicotine, citing its superior chemical stability and sensory profile over synthetic alternatives.

 

• Nicotine Salt Innovations: The company is developing a unique nicotine salt with a novel carrier, designed to enhance compatibility across different NGP products.

 

• Future of Nicotine Pouches: As demand grows, optimizing pouch whiteness, release timelines, and user experience is key. Nico Orgo is investing in R&D and exploring MCC replacement solutions to improve nicotine absorption.

 

• India’s Role in the Global Nicotine Supply Chain: As the world’s largest nicotine producer (85% market share), Laijawala highlights India’s supply chain reliability, sustainability, and cost efficiency, while noting that some smaller manufacturers operate intermittently, whereas Nico Orgo runs a 24/7 production model to ensure continuous supply.

 

Nicotine’s Central Role in the Evolving NGP Industry

 

As a core raw material in next-generation products (NGPs), nicotine plays a critical role in shaping global innovation and regulatory discussions. With the rise of nicotine pouches, advanced e-cigarette formulations, and pharmaceutical nicotine applications, demand for high-purity nicotine continues to grow. Against this backdrop, Nico Orgo, a leading Indian nicotine manufacturer, stands as a major player in the global supply chain.

 

“Nicotine is at the heart of all NGP innovation. As manufacturers, it is our responsibility to ensure nicotine’s quality and stability evolve alongside new product categories.”

 

Navigating Regulatory Challenges: The Industry’s Shifting Landscape and Nico Orgo’s Strategy

 

Founded in 1979—long before the first NGPs entered the market—Nico Orgo established itself as a key supplier to major industry players, initially providing nicotine to Mitsubishi for the Japanese market. Following shifts in regulatory landscapes, the company transitioned to supplying pharmaceutical-grade nicotine globally and, in the last 15 years, has expanded its footprint in the NGP sector.

 

Today, Nico Orgo supplies high-purity nicotine for a wide range of applications, including vapes, nicotine pouches, disposable devices, and other novel products, alongside pharmaceutical formulations such as nicotine gums, lozenges, and patches. Operating across the United States, Europe, India, and the Far East, the company stands among the largest nicotine producers globally, with a record-breaking 23.5 metric tons of EP-grade nicotine production in January 2024.

 

"Our goal is to engineer the next generation of nicotine—odorless, colorless, and optimized for new delivery systems. The industry is shifting towards fume-free, discreet nicotine solutions, and we are positioning ourselves at the forefront of this transformation," says Laijawala. "We’ve also learned that in the NGP space, taste and smell matter significantly more than just analytical purity. Our focus has been to develop nicotine that enhances the sensory experience across different product verticals."

 

The company’s strategy in the NGP sector focuses on innovation and consistency in supply. It is investing in next-generation nicotine formulations that eliminate vapor and fumes, making products more discreet, safe, and usable in all environments. Additionally, Nico Orgo is pioneering custom nicotine salts, designed with unique carriers that optimize performance in different NGP categories.

 

Advancing Nicotine Innovation: The Challenge of Sensory Precision

 

Nico Orgo’s research and development efforts are centered on improving nicotine purity, stability, and usability. The company has achieved specifications that surpass USP/EP standards, focusing on eliminating impurities that cause oxidation, discoloration, and unwanted odors.

 

As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview
Nico Orgo specializes in high-purity, sustainable nicotine production|Provided by Interviewee

 

"Achieving purity beyond standard USP/EP requirements is no easy feat. We have identified and eliminated compounds that cause oxidation and bad odors—this has been one of our strongest achievements," explains Laijawala. "A large part of our R&D is dedicated to ensuring that our nicotine remains clear, stable, and resistant to oxidation, which is crucial for product consistency."

 

The firm is also working on advanced nicotine pouch formulations, enhancing whiteness and refining nicotine-release timelinesto create superior user experiences. "In the NGP space, sensory experience is just as important as analytical purity. Different product verticals demand unique nicotine formulations, and we have been able to tailor our nicotine accordingly," he adds.

 

As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview
High-purity nicotine produced at Nico Orgo’s laboratory | Provided by Interviewee

 

Additionally, the company is exploring 6-Methyl Nicotine technology, but Laijawala notes that its safety remains debated, which could impact adoption.

 

Industry Trends and the Future of Nicotine: Natural Nicotine’s Superiority Over Synthetic Alternatives

 

The nicotine industry stands at a crossroads, influenced by shifting regulations and emerging technologies. Key global trends include:

 

• Regulatory changes: Governments worldwide are reconsidering disposable vape bans, which could drive demand for alternative nicotine delivery systems.

 

• Synthetic nicotine debate: Despite growing interest, synthetic nicotine has struggled to match the sensory and chemical qualities of naturally extracted nicotine.

 

• Market diversification: The demand for alternative nicotine delivery methods, including pouches and novel formulations, continues to rise.

 

"The industry is in flux, with potential bans on disposable vapes in key markets. This could pave the way for a resurgence of liquid nicotine products and alternative delivery formats outside of China," notes Laijawala. "Additionally, we see significant R&D efforts in designing nicotine for pouches—whether in terms of color stability or optimizing the delivery timeframe for a better user experience."

 

India’s Critical Role in Global Nicotine Supply: Market Strength vs. Regulatory Hurdles

 

As the world’s leading supplier of nicotine, accounting for roughly 85% of global production, India plays an indispensable role in the industry. Indian manufacturers benefit from well-established supply chains, stable production costs, and a regulatory framework that, while restrictive on domestic NGP sales, enables a strong export market.

 

Unlike other regions where nicotine sourcing is fragmented, India offers a consistent and scalable supply. Additionally, Indian nicotine production utilizes tobacco fines, which would otherwise go unused, contributing to a more sustainable supply chain. As a byproduct, the residual materials serve as cost-effective fertilizers, benefiting local agriculture.

 

"India’s nicotine industry is uniquely positioned. We operate within a well-structured supply chain, and our ability to efficiently process tobacco fines ensures that nothing goes to waste. This sustainability factor is one of our biggest strengths," Laijawala highlights. "Our road infrastructure, well-established purchase channels, and stable currency make India one of the most reliable sources for nicotine production globally."

 

The Future of Nicotine: Insights from Kartik Laijawala on Industry Shifts

 

The future of nicotine will be shaped by innovation, regulatory adaptation, and market diversification. With governments tightening regulations on disposable vapes, alternative delivery methods such as enhanced nicotine pouches and pharmaceutical applications could gain traction.

 

While synthetic nicotine continues to evolve, it has yet to surpass the organoleptic and chemical advantages of naturally extracted nicotine.

 

“We have received synthetic nicotine samples from several manufacturers, but their chemical composition and sensory characteristics still lag behind naturally derived nicotine.”

 

As the NGP industry expands, demand for high-purity nicotine will remain strong, positioning Nico Orgo and India as central players in the industry’s future. With a rapidly shifting global landscape, Nico Orgo’s strategic vision and technological advancements will continue to drive innovation in nicotine production.

 

2Firsts welcomes article submissions, interview opportunities, or commentary. Please contact us at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn here.

German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Holdings Limited will acquire 100% of PT Broad Far Indonesia through two wholly owned subsidiaries for approximately RMB 90 million. The Indonesian company manufactures and sells heat-not-burn tobacco sticks and provides OEM/ODM services. The sellers are part of a related-party group controlled by Huabao International Chair and controlling shareholder Zhu Linyao. PT Broad Far Indonesia generated $4.37 million in revenue and $177,000 in profit after tax in the first half of 2026, while net assets stood at about $326,000 at June-end. An independent valuer assessed the company’s equity at approximately RMB 93.06 million. Following completion, the HNB manufacturing operation will be consolidated into Huabao International.
News
Sep.29 by 2Firsts Perspectives
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07